Collegium Pharmaceutical, Inc. <COLL.O>: Truist Securities cuts target price to $49 from $58
COLL•Related News
Astronics outlines aerospace growth strategy at Jefferies conference presentation
ATRO•
Energy companies gain as Brent crude rises above $100/barrel mark
XLE•
Pet products retailer Chewy's Q2 revenue edges past estimates on recurring sales strength
CHWY•
Nike, Inc. <NKE.N>: BMO initiates coverage with underperform rating; target price $30
NKE•
Tyra Biosciences reports 79% response rate in Phase 2 bladder cancer study of dabogratinib at 60 mg dose
TYRA•